Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.53%906K | 21.83%3.78M | 81.23%1.95M | 22.19%760K | 53.95%1.03M | 18.93%798K | -20.08%3.1M | 4.10%1.08M | -20.66%622K | 12.40%671K |
| Cost of revenue | -31.85%261K | -21.31%1.55M | -70.27%228K | -27.73%331K | -21.05%285K | 17.13%383K | 7.68%1.96M | 76.08%767K | 28.65%458K | -3.73%361K |
| Gross profit | 55.42%645K | 96.45%2.23M | 457.28%1.72M | 161.59%429K | 141.29%748K | 20.64%415K | -44.73%1.14M | -48.33%309K | -61.68%164K | 39.64%310K |
| Operating expense | 4.95%1.27M | -37.76%4.69M | -43.79%1.06M | -34.70%1.1M | 537.13%1.29M | -40.89%1.21M | -10.11%7.53M | -26.36%1.89M | -12.24%1.68M | -89.46%202K |
| Selling and administrative expenses | 0.42%1.2M | -37.05%4.24M | -32.09%1.26M | -28.23%1.22M | -33.67%1.31M | -42.54%1.2M | -18.55%6.74M | -16.41%1.86M | -12.84%1.7M | -2.52%1.98M |
| -Selling and marketing expense | ---- | -30.35%208.84K | ---- | ---- | ---- | ---- | 85.37%299.83K | ---- | ---- | ---- |
| -General and administrative expense | 0.42%1.2M | -37.36%4.03M | -32.09%1.26M | -28.23%1.22M | -33.67%1.31M | -42.54%1.2M | -20.63%6.44M | -9.85%1.86M | -12.84%1.7M | -2.52%1.98M |
| Other operating expenses | 366.67%70K | -43.78%447.58K | 302.94%137K | 100.00%14K | -70.83%14K | 15.38%15K | 634.46%796.18K | -63.60%34K | 40.00%7K | 500.00%48K |
| Total other operating income | --0 | -89.40%215K | --335K | 317.65%142K | -97.97%37K | --0 | --2.03M | ---- | -30.61%34K | 1,456.41%1.82M |
| Operating profit | 21.30%-628K | 61.59%-2.46M | 141.66%659K | 55.98%-666K | -599.07%-539K | 53.28%-798K | -1.14%-6.4M | 19.70%-1.58M | -2.02%-1.51M | 106.37%108K |
| Net non-operating interest income (expenses) | 0.00%-5K | -38.19%-38.31K | -400.00%-25K | 28.57%-5K | 42.86%-4K | 44.44%-5K | 35.52%-27.72K | 58.29%-5K | 12.50%-7K | 41.67%-7K |
| Non-operating interest expense | 0.00%5K | 38.19%38.31K | 400.00%25K | -28.57%5K | -42.86%4K | -44.44%5K | -35.52%27.72K | -58.29%5K | -12.50%7K | -41.67%7K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 27.88%-269.25K | -437.13%-373.35K | ||||||||
| Less:Write off | ---- | -27.88%269.25K | ---- | ---- | ---- | ---- | 437.13%373.35K | ---- | ---- | ---- |
| Other non-operating income (expenses) | -86.77%268.26K | 11,266.67%335K | 5.92%2.03M | -3K | ||||||
| Income before tax | 21.17%-633K | 47.67%-2.5M | 139.95%634K | 55.86%-671K | -637.62%-543K | 53.23%-803K | -5.47%-4.77M | -1,059.73%-1.59M | -1.95%-1.52M | 105.92%101K |
| Income tax | 0 | 2,870.81%522.57K | 2,811.11%524K | 0 | 0 | 0 | -60.79%17.59K | 122.74%18K | 0 | 0 |
| Net income | 21.17%-633K | 36.94%-3.02M | 106.85%110K | 55.86%-671K | -637.62%-543K | 53.23%-803K | -4.82%-4.79M | -2,681.73%-1.61M | 5.88%-1.52M | 105.92%101K |
| Net income continuous operations | 21.17%-633K | 36.94%-3.02M | 106.85%110K | 55.86%-671K | -637.62%-543K | 53.23%-803K | -4.82%-4.79M | -2,681.73%-1.61M | 5.88%-1.52M | 105.92%101K |
| Noncontrolling interests | -100.35%-1K | 47.23%-220.4K | 129.17%14K | 136.26%62K | 291.11%258K | 674.00%287K | -187.88%-417.64K | 37.72%-48K | -968.75%-171K | -419.23%-135K |
| Net income attributable to the company | 42.02%-632K | 35.96%-2.8M | 106.17%96K | 45.66%-733K | -439.41%-801K | 34.61%-1.09M | 1.18%-4.37M | -8,135.71%-1.56M | 15.63%-1.35M | 114.04%236K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 42.02%-632K | 35.96%-2.8M | 106.17%96K | 45.66%-733K | -439.41%-801K | 34.61%-1.09M | 1.18%-4.37M | -8,135.71%-1.56M | 15.63%-1.35M | 114.04%236K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 44.44%-0.001 | 40.00%-0.0045 | 107.41%0.0002 | 47.83%-0.0012 | -450.00%-0.0014 | 37.93%-0.0018 | 1.32%-0.0075 | -0.0027 | 14.81%-0.0023 | 113.79%0.0004 |
| Diluted earnings per share | 44.44%-0.001 | 40.00%-0.0045 | 107.41%0.0002 | 47.83%-0.0012 | -450.00%-0.0014 | 37.93%-0.0018 | 1.32%-0.0075 | -0.0027 | 14.81%-0.0023 | 113.79%0.0004 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.